Protocatechuic acid inhibits LPS‐induced mastitis in mice through activating the pregnane X receptor

Mastitis refers to the inflammation in the mammary gland caused by various reasons. Protocatechuic acid (PCA) exerts anti‐inflammatory effect. However, no studies have shown the protective role of PCA on mastitis. We investigated the protective effect of PCA on LPS‐induced mastitis in mice and elucidated its possible mechanism. LPS‐induced mastitis model was established by injection of LPS into the mammary gland. The pathology of mammary gland, MPO activity and inflammatory cytokine production were detected to evaluate the effects of PCA on mastitis. In vivo, PCA significantly attenuated LPS‐induced mammary pathological changes, MPO activity, TNF‐α and IL‐1β production. In vitro, the production of inflammatory cytokines TNF‐α and IL‐1β was significantly reduced by PCA. Furthermore, LPS‐induced NF‐κB activation was also inhibited by PCA. In addition, PCA was found to activate pregnane X receptor (PXR) transactivation and PCA dose‐dependently increased the expression of PXR downstream molecule CYP3A4. In addition, the inhibitory effect of PCA on inflammatory cytokine production was also reversed when PXR was knocked down. In conclusion, the protective effects of PCA on LPS‐induced mastitis in mice through regulating PXR.